Patents by Inventor Gabriel Saucy

Gabriel Saucy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4000131
    Abstract: Homologation of .alpha.,.beta.-polyene unsaturated aldehydes and ketones to form .alpha.,.beta.-unsaturated aldehydes via epoxidation of the ketone or aldehyde and intermediates in this process such as .beta.,.gamma.-unsaturated polyene aldehydes.
    Type: Grant
    Filed: May 10, 1974
    Date of Patent: December 28, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Rosenberger, Gabriel Saucy
  • Patent number: 4000169
    Abstract: Asymmetric synthesis of optically active 3,7,11-trimethyl-dodecan-1-ol, an intermediate for producing optically active vitamin E, from isovaleraldehyde or prenal including intermediates in this synthesis.
    Type: Grant
    Filed: January 27, 1975
    Date of Patent: December 28, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Ka-Kong Chan, Gabriel Saucy
  • Patent number: 3994926
    Abstract: The intermediates and processes of this disclosure provide a new stereo-specific total synthesis of steroidal materials having known valuable pharmacological properties. A fundamental feature of this disclosure is the utilization of aryl ketals, preferably phenylenedioxy ketals derived from catechol as protective groups for oxo moieties in the polycyclic intermediates used in the aforesaid total synthesis.
    Type: Grant
    Filed: June 9, 1975
    Date of Patent: November 30, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Rosenberger, Gabriel Saucy
  • Patent number: 3994930
    Abstract: A multi-step, stereospecific total synthesis of steroids utilizing intermediates having a cyanoalkyl A-ring precursor is disclosed. The initial starting materials for this process are the relatively inexpensive and commercially available reagents .gamma.-butyrolactone and sodium cyanide. The process is suitable for the preparation of racemic or optically active, medicinally valuable steroids, particularly 19-norsteroids. It is a feature of this process that conditions employed during the multiple step synthesis are selected so as to retain the normally labile nitrile group even during hydrogenation and hydrolysis steps. In this manner, it is possible to employ the nitrile group as an A-ring precursor without resorting the protective groups as was heretofore found necessary in previous steroid total synthesis processes.
    Type: Grant
    Filed: September 15, 1975
    Date of Patent: November 30, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Noal Cohen, Michael Rosenberger, Gabriel Saucy
  • Patent number: 3991084
    Abstract: A multi-step, stereospecific total synthesis of steroids utilizing intermediates having a cyanoalkyl A-ring precursor is disclosed. The initial starting materials for this process are the relatively inexpensive and commercially available reagents .gamma.-butyrolactone and sodium cyanide. The process is suitable for the preparation of racemic or optically active, medicinally valuable steroids, particularly 19-norsteroids. It is a feature of this process that conditions employed during the multiple step synthesis are selected so as to retain the normally labile nitrile group even during hydrogenation and hydrolysis steps. In this manner, it is possible to employ the nitrile group as an A-ring precursor without resorting to protective groups as was heretofore found necessary in previous steroid total synthesis processes.
    Type: Grant
    Filed: March 13, 1974
    Date of Patent: November 9, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Noal Cohen, Michael Rosenberger, Gabriel Saucy
  • Patent number: 3989724
    Abstract: Stereo-specific total synthesis of steroidal materials. 7-Substituted 3-oxo-1-heptenes or variants thereof are reacted with 2-alkylcycloalkane-1,3-diones yielding 3-substituted 6a .beta.-alkyl-cyclopenta [f] [1] benzopyrans or naphtho [2,1-b] pyrans. These are then subjected to a selective catalytic hydrogenation followed by an introduction of a hydroxy, alkoxy or acyloxy group at the 4a-position to produce a 3-substituted 6a .beta.,4a-hydroxy, alkoxy or acyloxy perhydrocyclopenta [f] [1] benzopyran or perhydro-naphtho [2,1-b] pyran. These latter compounds are then converted into 4- or 5-(3-oxoalkyl)perhydroindene-5-ones or perhydronaphthalene-6-ones which in turn can be converted to known steroidal materials by known methods.
    Type: Grant
    Filed: March 13, 1974
    Date of Patent: November 2, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Gabriel Saucy
  • Patent number: 3985771
    Abstract: The novel intermediates and processes of this invention provide a new synthetic route for the preparation of pharmaceutically valuable 19-nor-steroids. Further, the intermediates and processes of the invention provide a novel route for the preparation of pharmaceutically valuable estrones. The present invention provides a facile total synthesis of 13.beta.-alkyl-C/D-trans-steroidal materials. This desirable result is obtained via a unique asymmetric induction followed by subsequent stereo-specific reaction steps. As a precursor to the steroidal Ring A, a 3,5-disubstituted-4-isoxazolylmethylene group is employed in this synthesis.
    Type: Grant
    Filed: June 5, 1974
    Date of Patent: October 12, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Gabriel Saucy, John William Scott
  • Patent number: 3984427
    Abstract: Vinyl ketones and Mannich-bases obtained therefrom are useful as intermediates in the total synthesis of steroids having valuable pharmacological properties. These compounds are prepared by the low temperature reaction of a vinyl Grignard e.g., vinyl magnesium chloride with substituted .gamma., .delta. or .epsilon. lactones followed, if desired, by reaction of the vinyl ketone obtained with a primary or secondary amine. Particular compounds prepared by this procedure include 2-(2-substituted aminoethyl)-6-substituted-2-hydroxy-tetrahydropyrans and the tautomers thereof.
    Type: Grant
    Filed: June 18, 1969
    Date of Patent: October 5, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Gabriel Saucy
  • Patent number: 3984428
    Abstract: 6[(4-Isoxazolyl)-methyl]perhydro-1H-benz[e]indenes, useful for the preparation of pharmaceutically valuable 19-norsteroids and estranes by degradation of the isoxazolylmethylene moiety followed by cyclization, is disclosed.
    Type: Grant
    Filed: May 21, 1974
    Date of Patent: October 5, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Gabriel Saucy, John William Scott
  • Patent number: 3972896
    Abstract: The intermediates and processes of this disclosure provide a new stereo-specific total synthesis of steroidal materials having known valuable pharmacological properties. A fundamental feature of this disclosure is the utilization of aryl ketals, preferably phenylenedioxy ketals derived from catechol as protective groups for oxo moieties in the polycyclic intermediates used in the aforesaid total synthesis.
    Type: Grant
    Filed: June 9, 1975
    Date of Patent: August 3, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Rosenberger, Gabriel Saucy
  • Patent number: 3965138
    Abstract: A multi-step, stereospecific total synthesis of steroids utilizing intermediates having a cyanoalkyl A-ring precursor is disclosed. The initial starting materials for this process are the relatively inexpensive and commercially available reagents .gamma.-butyrolactone and sodium cyanide. The process is suitable for the preparation of racemic or optically active, medicinally valuable steroids, particularly 19-norsteroids. It is a feature of this process that conditions employed during the multiple step synthesis are selected so as to retain the normally labile nitrile group even during hydrogenation and hydrolysis steps. In this manner, it is possible to employ the nitrile group as an A-ring precursor without resorting to protective groups as was heretofore found necessary in previous steroid total synthesis processes.
    Type: Grant
    Filed: July 28, 1975
    Date of Patent: June 22, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Noal Cohen, Michael Rosenberger, Gabriel Saucy
  • Patent number: 3960967
    Abstract: A process for the preparation of vitamin A and esters thereof from the condensation of a sulfone of 2-methyl-4-hydroxy-but-2-ene and an activated derivative of 3-methyl-5-(2,6,6-trimethyl-cyclohexen-1-yl)penta-2,4-diene including intermediates therein.
    Type: Grant
    Filed: July 19, 1974
    Date of Patent: June 1, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Gary Lee Olson, Gabriel Saucy
  • Patent number: 3960896
    Abstract: The intermediates and processes of this disclosure provide a new stereo-specific total synthesis of steroidal materials having known valuable pharmacological properties. A fundamental feature of this diclosure is the utilization of aryl ketals, preferably phenylenedioxy ketals derived from catechol as protective groups for oxo moieties in the polycyclic intermediates used in the aforesaid total synthesis.
    Type: Grant
    Filed: June 9, 1975
    Date of Patent: June 1, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Rosenberger, Gabriel Saucy
  • Patent number: 3960895
    Abstract: The intermediates and processes of this disclosure provide a new stereo-specific total synthesis of steroidal materials having known valuable pharmacological properties. A fundamental feature of this disclosure is the utilization of aryl ketals, preferably phenylenedioxy ketals derived from catechol as protective groups for oxo moieties in the polycyclic intermediates used in the aforesaid total synthesis.
    Type: Grant
    Filed: June 9, 1975
    Date of Patent: June 1, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Rosenberger, Gabriel Saucy
  • Patent number: 3950358
    Abstract: The intermediates and processes of this disclosure provide a new stereo-specific total synthesis of steroidal materials having known valuable pharmacological properties. A fundamental feature of this disclosure is the utilization of aryl ketals, preferably phenylenedioxy ketals derived from catechol as protective groups for oxo moieties in the polycyclic intermediates used in the aforesaid total synthesis.
    Type: Grant
    Filed: October 15, 1974
    Date of Patent: April 13, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Rosenberger, Gabriel Saucy
  • Patent number: 3948951
    Abstract: The intermediates and processes of this disclosure provide a new stereo-specific total synthesis of steroidal materials having known valuable pharmacological properties. A fundamental feature of this disclosure is the utilization of aryl ketals, preferably phenylenedioxy ketals derived from catechol as protective groups for oxo moieties in the polycyclic intermediates used in the aforesaid total snythesis.
    Type: Grant
    Filed: October 15, 1974
    Date of Patent: April 6, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Rosenberger, Gabriel Saucy
  • Patent number: 3947473
    Abstract: The (6-hydroxy-chroman-2-yl) acetic or carboxylic acid derivatives useful as antioxidants and a method for preparing these derivatives from hydroquinones and intermediates in this synthesis as well as the use of these derivatives as intermediates in the preparation of optically active alpha-tocopherol.
    Type: Grant
    Filed: November 19, 1973
    Date of Patent: March 30, 1976
    Assignee: Hoffman-La Roche Inc.
    Inventors: John William Scott, David Richard Parrish, Gabriel Saucy
  • Patent number: 3932519
    Abstract: A multi-step, stereospecific total synthesis of steroids is disclosed. The starting materials for this process are the relatively inexpensive and readily available m-alkoxy acetophenones. The process is suitable for the preparation of racemic or optically active, medicinally valuable steroids, particularly A-ring aromatic steroids. This process features an early optical resolution and a unique asymmetric induction which insures the correct stereochemistry of the final steroidal product.
    Type: Grant
    Filed: October 16, 1973
    Date of Patent: January 13, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Noal Cohen, Gabriel Saucy